Robert Ford

Robert Ford is an American business executive who is the chairman and chief executive of Abbott Laboratories, one of the world's largest and most diversified healthcare companies. Born in 1973, Ford built his career inside Abbott over many years, rising through its medical device businesses before taking the top job in March 2020, just as the COVID-19 pandemic began to reshape the world. His early tenure was defined by leading Abbott's major role in the global response to the virus, and he has since steered the company across its broad portfolio of devices, diagnostics, nutrition and medicines.

This profile covers who Robert Ford is, his early life and education, his long career at Abbott, his leadership of the company, his net worth and his current role.

Early Life and Education

Robert B. Ford was born in 1973. He pursued his higher education in the United States, earning a bachelor's degree from Boston College. He went on to complete a master of business administration at the Haas School of Business at the University of California, Berkeley, combining a strong academic foundation with formal management training.

This educational background prepared him for a career in the business side of healthcare, an industry that demands both an understanding of complex science and technology and the commercial discipline to run large, global operations. He would spend the bulk of his professional life at a single company, Abbott, developing deep institutional knowledge.

A Career Built at Abbott

Robert Ford joined Abbott and built essentially his entire senior career there, a path that gave him an unusually thorough understanding of the company's diverse businesses. He worked extensively in Abbott's medical devices operations, including its cardiovascular and diabetes care businesses, areas central to the company's growth and innovation.

Over the years he took on roles of increasing scope and responsibility, leading major divisions and demonstrating an ability to grow important product lines. His work in diabetes care, in particular, was associated with the success of continuous glucose monitoring technology, one of Abbott's signature growth areas. This record of operating success within the company positioned him as a leading candidate to eventually run it.

Rising to the Top

Ford was named chief operating officer of Abbott, the role that effectively designated him as the heir apparent to lead the company. He took over as chief executive in March 2020, at one of the most consequential moments imaginable, as the COVID-19 pandemic swept across the globe and threw the healthcare industry into the center of world events.

His timing meant that his early leadership was inseparable from the pandemic. Abbott became a major player in the response, developing and producing large volumes of diagnostic tests, including rapid tests that became widely used around the world. Leading the company through this period, balancing the surge in demand for testing with the disruption to its other businesses, was a defining trial of his early tenure.

Leading a Diversified Healthcare Giant

Abbott is unusual among major healthcare companies for the breadth of its portfolio. It spans medical devices, including heart devices and diabetes monitors, diagnostics, nutrition products such as infant formula and adult nutrition, and established pharmaceuticals sold largely outside the United States. Under Robert Ford, the company has continued to emphasize this diversification as a source of stability and growth.

He has guided Abbott through the shifting landscape that followed the height of the pandemic, including the decline in COVID testing demand and challenges in specific businesses, while continuing to invest in innovation, particularly in medical devices. His leadership has focused on sustaining the company's reputation for steady performance and broad based strength across healthcare markets, and Abbott has remained one of the most valuable and respected companies in the sector.

Robert Ford Net Worth

Robert Ford net worth is not disclosed as a precise figure, but it is generally estimated in the range of tens of millions of dollars. As a longtime executive and now chief executive of Abbott, his wealth comes from years of compensation, much of it in company stock and long term incentives tied to performance, rather than from founding a business.

Because so much of his wealth is held in Abbott shares and equity awards, its value moves with the company's stock price. His financial position reflects a long and successful career as a senior executive at one large, stable healthcare company.

Personal Life

Robert Ford generally maintains a private personal life, with his public identity centered on his leadership of Abbott. He has an international background and is known for a focus on innovation and operational execution. As the leader of a major healthcare company, he participates in broader discussions about the future of medicine, devices and global health, but he keeps the details of his private life largely out of public view.

Achievements and Influence

Robert Ford's central achievement is rising through Abbott's ranks to lead one of the world's premier diversified healthcare companies, and steering it through the extraordinary challenges of the pandemic in his first year as chief executive. His influence is felt across the medical device and diagnostics industries, particularly in areas such as continuous glucose monitoring and cardiovascular devices, and in the broader healthcare sector where Abbott is a major force.

Robert Ford in 2026

As of 2026, Robert Ford continues to serve as chairman and chief executive of Abbott Laboratories. The themes around him include driving growth in medical devices, advancing innovation in diabetes and heart care, managing the company's broad and global portfolio, and maintaining Abbott's standing as one of the steadiest and most respected companies in healthcare.

He is profiled alongside other leaders in the Health sector on Founder Canon, the executives shaping how the world stays well.